The Max gene encodes a protein that interacts specifically with the Myc protein to form a heterodimer with high affiity for the specific cognate DNA binding site of Myc.
hybridized specifically to a Max cDNA probe in all human and murine cell lines that were tested. Unlike Myc, the steady-state level of Max RNA is not signicantly modulated with respect to proliferation or differentiation. Max RNA is expressed in quiescent BALB/c 3T3 cells and is modestly increased 3 h after addition of serum to the quiescent cells. In contrast to Myc RNA, Max RNA does not decline immediately upon induction of differentiation of HL60 cells by dimethyl sulfoxide, and only a modest decrease of Max RNA was observed 72 h after induction of differentiation. Unlike Myc RNA, Max RNA is relatively stable with a half-life of >3 h and, therefore, does not exhibit the characteristic short half-life of RNAs encoded by most immediate early genes. The human Max gene was localized to chromosome 14, band q23. With respect to the recurring abnormalities in human tumors, this region of chromosome 14 is involved in deletions in B-cell chronic lymphocytic leukemia and malignant lymphomas and in the 12;14 translocation in uterine leiomyomas.
The processes of cell proliferation and differentiation are closely correlated with changes in the level of expression of the protooncogene c-myc (for reviews, see refs. 1 and 2). During the induction of cell growth by the addition of growth factors and mitogens to quiescent cells, the steady-state level of Myc RNA is transiently increased and remains at relatively high levels in proliferating cells (3) (4) (5) . During cellular differentiation, however, the level of Myc RNA expression decreases as cells enter a nonproliferative state (6) (7) (8) . Furthermore, it is well documented that deregulation of Myc expression is associated with tumorigenesis (1, 2, 9, 10) .
Despite much data suggesting the importance of Myc in these events, little is known about the mechanism of its action. The similarity of the predicted structure of the protein's domains with other transcription factors and its nuclear localization suggest that it may regulate transcription of other genes (11 (16) .
RNA Analysis. Total RNA was collected from cells by the guanidinium isothiocyanate method, followed by centrifugation through a CsCI cushion (19) . RNA Northern blot analysis was performed as described (20 (16) . The Myc probe contains 600 nt from the C terminus region of human Myc coding region and was transcribed by SP6 RNA polymerase from a linearized pGEMMYC plasmid. The Myc probe that encompasses the two human Myc promoters, P1 and P2, was as described (21) . The /2-microglobulin probe was transcribed from a pSP65 plasmid containing a 145-nt fragment from the 5' end of the human j32-microglobulin cDNA (22) . RNase treatment was performed as described (21) . RNaseresistant fragments were analyzed by electrophoresis in a 5% polyacrylamide sequencing gel.
Fluorescence in Situ Chromosomal Hybridization. Human metaphase cells were prepared from phytohemagglutininstimulated peripheral blood lymphocytes. Max probes 6.4 and 6.8 contain 18-kilobase (kb) and 14-kb genomic DNA inserts, respectively, and were isolated after screening of A EMBL3 random human genomic library with the Max cDNA clone. The procedure used for fluorescence in situ hybridization is a modification (23) of the method described by Lichter et al. (24) . Biotin-labeled probes were prepared by nick-translation using biotin-conjugated dUTP, Bio-11-dUTP (Enzo Diagnostics). Hybridization was detected with fluorescein-conjugated avidin (Vector Laboratories), and chromosomes were identified by staining with 4',6-diamidino-2-phenylindole dihydrochloride.
RESULTS
Max Encodes a Maijor 2.0-kb mRNA and a Minor 1.7-kb mRNA. The expression of Max RNA was first analyzed in cell lines from various tissues of human or murine origin. A partial Max cDNA, encompassing the full-length coding region of the gene, was obtained by using the PCR, a human cDNA library, and primers flanking the open reading frame reported by Blackwood and Eisenman (16) . The partial cDNA obtained was radiolabeled and used for Northern blot analysis of total RNA isolated from primary normal human skin fibroblasts, the human B-cell lines BJAB and RPMI 1788, mouse BALB/c 3T3 cells, and WEHI-231 cells, a mouse lymphoid tumor cell line. As shown in Fig. 1 , we observed a major RNA species of 2.0 kb and a minor species of 1.7 kb that hybridized specifically to Max cDNA. Max mRNA was expressed in all cell lines tested and the sizes of the murine and the human Max RNAs were identical. Both mRNA species of 2.0 kb and 1.7 kb were also observed previously in mouse NIH 3T3 cells (17) . The origin of the minor 1.7-kb mRNA is not yet clear, but it is very likely that the 2.0-kb mRNA encodes the full-length Max protein as reported (16, 17) . The 1.7-kb mRNA may represent a product of alternative splicing and may encode a Max protein with a deletion of 9 amino acids in the N terminus portion of the protein (16, 17) .
Max RNA Is Constitutively Expressed as Myc RNA Levels Are Altered. Max is a specific heterodimerization partner of Myc and enhances the DNA binding activity of Myc to its cognate specific DNA binding site (16, 17) . Since Myc expression is tightly linked to cell proliferation, we were interested in studying the expression of Max in various settings in which Myc expression is regulated.
To examine the regulation of Max RNA expression and to compare its level of expression to that of Myc, we performed Northern blot analysis and quantitative RNase protection analysis of Myc and Max RNAs. For the RNase protection assays, a fragment that protects 317 nt of the human Max RNA was used. For the analysis of Myc RNA, a fragment that contains the human Myc first exon or a 600-base-pair fragment of human Myc cDNA was used.
To study the regulation of Max expression after serum stimulation of quiescent fibroblasts, we used mouse BALB/c 3T3 fibroblasts in which Myc RNA level is significantly induced after serum stimulation (3). Myc and Max RNAs were analyzed in quiescent or serum-stimulated cells. The RNA level was determined by Northern blot analysis (Fig. 2) and by RNase protection (data not shown). We observed that Myc RNA was transiently induced after serum addition reaching an -40-fold induction at 3 h and decreasing at 15 h after addition of serum ( Fig. 2A) . Unlike Myc RNA, Max RNA was expressed in quiescent cells and only an -3-fold induction (as measured by densitometric analysis) of both Max RNAs at 2.0 kb and 1.7 kb occurred 3 h after addition of serum. This induction remained at the same level 15 h after serum addition (Fig. 2B) . A similar induction of Max RNA was observed (17) after serum stimulation of quiescent NIH 3T3 cells. Myc RNA level declines when human myeloid leukemia cells, HL60, are induced to differentiate (6, 25, 26) . To study the regulation of Max expression during differentiation of HL60 cells, the cells were induced to differentiate with 1.5% DMSO. RNA was extracted from the cells at various times after addition of DMSO and analyzed by quantitative RNase protection (Fig. 3) . In agreement with previous reports (6, 26), a significant decline in Myc RNA level was observed 12 h after addition ofDMSO (Fig. 3B, lane 3) , and Myc RNA was almost undetectable after 72 h (Fig. 3B, lane 5) . Max RNA, however, was constitutively expressed during the differentiation of HL60 cells (Fig. 3A) , and only a slight decrease in Max RNA level was observed at late time points after A B induction of differentiation (Fig. 3A, (27) (28) (29) . To determine whether a parallel increase in Max RNA level can be observed in Burkitt lymphoma cells, we analyzed the Myc and Max RNA levels in these cells. The RNA was analyzed by a quantitative RNase protection assay in which probes for Myc and Max with the same specific activity were used; the relative abundance ofMyc and Max RNA was determined in consideration of the length of the protected fragment and the number of labeled uridines in each fragment. In several Burkitt lymphoma cell lines that we tested (ST486, PA682, EB-2, and RAMOS) and in BJAB, a human B-cell line, the level of Myc RNA was greater than or comparable to that of Max (Fig. 4,  lanes 4-7) . In the human B-cell line RPMI 1788, however, the level of Max RNA was greater than that of Myc (Fig. 4, no evidence that the Max gene is rearranged or translocated in Burkitt lymphoma, we assume that it is actively transcribed in this developmental stage of B cells as it is in quiescent BALB/c 3T3 cells (Fig. 2) and in differentiating HL60 cells (Fig. 3) .
Max RNA Is Stable. Using RNase protection assays, we measured the half-life of Max and Myc RNA collected from HL60 cells at various times after treatment with actinomycin D. As shown in Fig. 5A , the stability of the Max RNA was -5 times greater than that of Myc RNA. Calculations from computer-generated curves (Fig. 5B) indicated a Max RNA half-life of -3.6 h and a Myc RNA half-life of 45 min. A similar value for the half-life of Max RNA was obtained with RNA isolated from BJAB cells (data not shown). Our value for the half-life of Myc RNA is slightly greater than that reported (30-32) ; we believe that this may be due to the amplification of Myc in HL60 cells that delays immediate inhibition of Myc transcription by actinomycin D. The halflife ofMax RNA is comparable to the average half-life of most mRNAs in mammalian cells (33) . Max mRNA, therefore, does not exhibit the characteristic short RNA half-life ofmost immediate early genes (34) .
Chromosomal Localization of the Max Gene. Deregulation of Myc expression in B-cell (Burkitt lymphoma) and T-cell lymphomas is associated with rearrangement and translocations involving one of the Myc alleles (9, 35) . To explore the possibility that lesions in the Max gene are also associated with the development of neoplasia, we identified the chromosomal location of Max.
To localize the Max gene, we performed fluorescence in situ hybridization of a biotin-labeled Max probe to normal metaphase chromosomes. Fluorescent signals from biotinlabeled probes were visualized as discrete green-yellow dots on unstained chromosomes; a specific signal was frequently observed on all four chromatids. Hybridization of both of the Max probes simultaneously resulted in specific labeling only of chromosome 14 (Fig. 6 ). Specific labeling of 14q23 was observed on one (1 cell), two (5 cells), three (11 cells), or all four (8 cells) chromatids of the chromosome 14 homologues in the 25 cells examined. Similar results were obtained in two additional hybridization experiments using these probes. In hybridizations using only a single probe (either 6.4 or 6.8), signal was also observed at 14q23; however, the signal was weaker than in those experiments in which both probes were hybridized simultaneously. Thus, the Max gene is localized to chromosome 14, band q23. The stability of Max RNA is approximately equal to the stability of most poly(A)+ RNA transcripts (33) . The turnover of this transcript is insufficient to account for modulation of Myc activity unless the degradation of Max RNA is somehow regulated. The long 3' noncoding region seen in the murine cDNA (17) may serve to govern its stability or as a template for a regulated nucleolytic activity that can degrade Max RNA after an appropriate stimulus. In addition, it is possible that, although Max RNA is expressed constitutively, the translation of this RNA is regulated. The turnover of Max protein has not been determined in the present studies but it may also be subject to regulation.
DISCUSSION
Another, and perhaps more likely, stage of regulation of Max activity may be at the posttranslational level. The C terminus of Max contains several consensus target sites for casein kinase II phosphorylation and several serine/ threonine residues that can be target for phosphorylation by other kinases. Deletion of this C-terminal portion of Max led to enhanced DNA binding both as a dimer with Myc and alone, as a homodimer (ref. 17; C. Amin and N.H., unpublished results). Thus, phosphorylation of Max could regulate its DNA binding abilities and its dimerization with Myc. This would provide a mechanism for rapid translation-independent control of Max activity and, therefore, could potentially modulate Myc activity.
By using fluorescence in situ hybridization, we have localized the Max gene to chromosome 14, band q23; this locus is proximal to the location ofthe Fos and transforming growth factor (3 genes (14q24) (ref. 37) . With respect to the recurring abnormalities in human tumors, this region of chromosome 14 is involved in deletions in B-cell chronic lymphocytic leukemia and malignant lymphomas [del(14)(q22-q24)] and in the t(12;14)(ql3-15;q23-24) in uterine leiomyomas (38) .
Whether the function or the regulation of the Max gene is altered as a result of these rearrangements is unknown. 
